Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Onxeo
Biotech
Fierce Biotech launches layoff tracker—Chutes and Ladders
Fierce Biotech launches layoff tracker as industry job cuts mount. Novartis says bye to CMO John Tsai. Doug Melton jumps from Harvard to Vertex.
Max Bayer
Apr 8, 2022 9:30am
Monopar files for $40M IPO to test chemo side effect drug
Aug 16, 2019 8:49am
Phase 3 hepatocellular carcinoma fail crushes Onxeo
Sep 12, 2017 10:12am
Clinigen makes 3 exclusive compassionate-use deals
Jun 21, 2017 10:33am
Clinigen to run access program for Onxeo’s belinostat in Europe
Apr 26, 2017 11:56am
